Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Chang

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Journal of Medicinal Chemistry|April 25, 2012
Imidazolopiperazines: lead optimization of the second-generation antimalarial agentsAdvait Nagle, Tao Wu, Kelli Kuhen, et al.
Cell Stem Cell|February 3, 2023
SYF2 suppression mitigates neurodegeneration in models of diverse forms of ALSGabriel R Linares, Yichen Li, Wen-Hsuan Chang, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung CancerDamien Vasseur, Shin Saito, Gunsagar S Gulati, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stagesBin Zou, Advait Nagle, Arnab K Chatterjee, et al.
Nature Communications|December 10, 2020
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblastsAngelo L Grauel, Beverly Nguyen, David Ruddy, et al.
Cancer Research Communications|November 1, 2024
Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic CancerSlavica Dimitrieva, Jon M Harrison, Jonathan Chang, et al.
Journal of Medicinal Chemistry|June 8, 2011
Imidazolopiperazines: hit to lead optimization of new antimalarial agentsTao Wu, Advait Nagle, Kelli Kuhen, et al.
MMWR. Morbidity and Mortality Weekly Report|October 1, 2020
CDC Deployments to State, Tribal, Local, and Territorial Health Departments for COVID-19 Emergency Public Health Response - United States, January 21-July 25, 2020Emilio Dirlikov, Ethan Fechter-Leggett, Stacy L Thorne, et al.
Journal of Medicinal Chemistry|June 8, 2013
Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trialsThomas H Marsilje, Wei Pei, Bei Chen, et al.
G3 (Bethesda, Md.)|February 9, 2021
A functional genomics screen identifying blood cell development genes in Drosophila by undergraduates participating in a course-based research experienceCory J Evans, John M Olson, Bama Charan Mondal, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Journal of Medicinal Chemistry|April 25, 2012
Imidazolopiperazines: lead optimization of the second-generation antimalarial agentsAdvait Nagle, Tao Wu, Kelli Kuhen, et al.
Cell Stem Cell|February 3, 2023
SYF2 suppression mitigates neurodegeneration in models of diverse forms of ALSGabriel R Linares, Yichen Li, Wen-Hsuan Chang, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung CancerDamien Vasseur, Shin Saito, Gunsagar S Gulati, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stagesBin Zou, Advait Nagle, Arnab K Chatterjee, et al.
Nature Communications|December 10, 2020
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblastsAngelo L Grauel, Beverly Nguyen, David Ruddy, et al.
Cancer Research Communications|November 1, 2024
Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic CancerSlavica Dimitrieva, Jon M Harrison, Jonathan Chang, et al.
Journal of Medicinal Chemistry|June 8, 2011
Imidazolopiperazines: hit to lead optimization of new antimalarial agentsTao Wu, Advait Nagle, Kelli Kuhen, et al.
MMWR. Morbidity and Mortality Weekly Report|October 1, 2020
CDC Deployments to State, Tribal, Local, and Territorial Health Departments for COVID-19 Emergency Public Health Response - United States, January 21-July 25, 2020Emilio Dirlikov, Ethan Fechter-Leggett, Stacy L Thorne, et al.
Journal of Medicinal Chemistry|June 8, 2013
Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trialsThomas H Marsilje, Wei Pei, Bei Chen, et al.
G3 (Bethesda, Md.)|February 9, 2021
A functional genomics screen identifying blood cell development genes in Drosophila by undergraduates participating in a course-based research experienceCory J Evans, John M Olson, Bama Charan Mondal, et al.
Pageof 10